Condensed Consolidated Statements of Operations (USD $)	3 Months Ended			9 Months Ended	6 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2014	Jun. 16, 2013 Resonant LLC
OPERATING EXPENSES
Research and development expenses	$ 622,722	$ 459,187	$ 489,120	$ 2,026,388	$ 195,403
General and administrative expenses	759,590	368,738	1,119,159	1,736,137	135,993
Depreciation and amortization	66,321	2,976	2,976	141,665	4,905
TOTAL OPERATING EXPENSES	1,448,633	830,901	1,611,255	3,904,190	336,301
OPERATING LOSS	(1,448,633)	(830,901)	(1,611,255)	(3,904,190)	(336,301)
OTHER INCOME (EXPENSE)
Interest and investment income	13,236	1,096	1,327	15,429
Interest expense	(10,087)	(559,380)	(728,484)	(2,817,949)	(199,961)
Fair value adjustments to warrant and derivative liabilities		164,258	164,258	(2,015,599)
Bridge warrant expense			(312,486)		(247,669)
Other income (expense)		(333)	(333)	1,163,772
TOTAL OTHER INCOME (EXPENSE)	3,149	(394,359)	(875,718)	(3,654,347)	(447,630)
LOSS BEFORE INCOME TAXES	(1,445,484)	(1,225,260)	(2,486,973)	(7,558,537)	(783,931)
Provision for income taxes		(1,256)	(1,256)	(800)	(800)
NET LOSS	$ (1,445,484)	$ (1,226,516)	$ (2,488,229)	$ (7,559,337)	$ (784,731)
NET LOSS PER SHARE - BASIC AND DILUTED (in dollars per share)	$ (0.21)	$ (1.23)	$ (2.49)	$ (2.04)
Weighted average shares outstanding - basic and diluted (in shares)	6,897,751	999,999	999,999	3,699,839